Table of Content

1 Report Overview
1.1 Pigmented Villonodular Synovitis Drug Definition
1.2 Market by Type
1.2.1 Global Pigmented Villonodular Synovitis Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Cabiralizumab
1.2.3 Emactuzumab
1.2.4 Mcs-110
1.2.5 Nilotinib
1.2.6 Others
1.3 Market Segment by Application
1.3.1 Global Pigmented Villonodular Synovitis Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Pigmented Villonodular Synovitis Drug Sales
2.1 Global Pigmented Villonodular Synovitis Drug Revenue Estimates and Forecasts 2018-2034
2.2 Global Pigmented Villonodular Synovitis Drug Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Pigmented Villonodular Synovitis Drug Revenue by Region
2.3.1 Global Pigmented Villonodular Synovitis Drug Revenue by Region (2018-2023)
2.3.2 Global Pigmented Villonodular Synovitis Drug Revenue by Region (2024-2034)
2.4 Global Pigmented Villonodular Synovitis Drug Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Pigmented Villonodular Synovitis Drug Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Pigmented Villonodular Synovitis Drug Sales Quantity by Region
2.6.1 Global Pigmented Villonodular Synovitis Drug Sales Quantity by Region (2018-2023)
2.6.2 Global Pigmented Villonodular Synovitis Drug Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Pigmented Villonodular Synovitis Drug Sales Quantity by Manufacturers
3.1.1 Global Pigmented Villonodular Synovitis Drug Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Pigmented Villonodular Synovitis Drug Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Pigmented Villonodular Synovitis Drug Sales in 2024
3.2 Global Pigmented Villonodular Synovitis Drug Revenue by Manufacturers
3.2.1 Global Pigmented Villonodular Synovitis Drug Revenue by Manufacturers (2018-2023)
3.2.2 Global Pigmented Villonodular Synovitis Drug Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Pigmented Villonodular Synovitis Drug Revenue in 2024
3.3 Global Pigmented Villonodular Synovitis Drug Sales Price by Manufacturers
3.4 Global Key Players of Pigmented Villonodular Synovitis Drug, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pigmented Villonodular Synovitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pigmented Villonodular Synovitis Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pigmented Villonodular Synovitis Drug, Product Offered and Application
3.8 Global Key Manufacturers of Pigmented Villonodular Synovitis Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Pigmented Villonodular Synovitis Drug Sales Quantity by Type
4.1.1 Global Pigmented Villonodular Synovitis Drug Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Pigmented Villonodular Synovitis Drug Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Pigmented Villonodular Synovitis Drug Sales Quantity Market Share by Type (2018-2034)
4.2 Global Pigmented Villonodular Synovitis Drug Revenue by Type
4.2.1 Global Pigmented Villonodular Synovitis Drug Historical Revenue by Type (2018-2023)
4.2.2 Global Pigmented Villonodular Synovitis Drug Forecasted Revenue by Type (2024-2034)
4.2.3 Global Pigmented Villonodular Synovitis Drug Revenue Market Share by Type (2018-2034)
4.3 Global Pigmented Villonodular Synovitis Drug Price by Type
4.3.1 Global Pigmented Villonodular Synovitis Drug Price by Type (2018-2023)
4.3.2 Global Pigmented Villonodular Synovitis Drug Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Pigmented Villonodular Synovitis Drug Sales Quantity by Application
5.1.1 Global Pigmented Villonodular Synovitis Drug Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Pigmented Villonodular Synovitis Drug Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Pigmented Villonodular Synovitis Drug Sales Quantity Market Share by Application (2018-2034)
5.2 Global Pigmented Villonodular Synovitis Drug Revenue by Application
5.2.1 Global Pigmented Villonodular Synovitis Drug Historical Revenue by Application (2018-2023)
5.2.2 Global Pigmented Villonodular Synovitis Drug Forecasted Revenue by Application (2024-2034)
5.2.3 Global Pigmented Villonodular Synovitis Drug Revenue Market Share by Application (2018-2034)
5.3 Global Pigmented Villonodular Synovitis Drug Price by Application
5.3.1 Global Pigmented Villonodular Synovitis Drug Price by Application (2018-2023)
5.3.2 Global Pigmented Villonodular Synovitis Drug Price Forecast by Application (2024-2034)
6 North America
6.1 North America Pigmented Villonodular Synovitis Drug Sales by Company
6.1.1 North America Pigmented Villonodular Synovitis Drug Revenue by Company (2018-2023)
6.1.2 North America Pigmented Villonodular Synovitis Drug Sales Quantity by Company (2018-2023)
6.2 North America Pigmented Villonodular Synovitis Drug Market Size by Type
6.2.1 North America Pigmented Villonodular Synovitis Drug Sales Quantity by Type (2018-2034)
6.2.2 North America Pigmented Villonodular Synovitis Drug Revenue by Type (2018-2034)
6.3 North America Pigmented Villonodular Synovitis Drug Market Size by Application
6.3.1 North America Pigmented Villonodular Synovitis Drug Sales Quantity by Application (2018-2034)
6.3.2 North America Pigmented Villonodular Synovitis Drug Revenue by Application (2018-2034)
6.4 North America Pigmented Villonodular Synovitis Drug Market Size by Country
6.4.1 North America Pigmented Villonodular Synovitis Drug Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Pigmented Villonodular Synovitis Drug Revenue by Country (2018-2034)
6.4.3 North America Pigmented Villonodular Synovitis Drug Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Pigmented Villonodular Synovitis Drug Sales by Company
7.1.1 Europe Pigmented Villonodular Synovitis Drug Sales Quantity by Company (2018-2023)
7.1.2 Europe Pigmented Villonodular Synovitis Drug Revenue by Company (2018-2023)
7.2 Europe Pigmented Villonodular Synovitis Drug Market Size by Type
7.2.1 Europe Pigmented Villonodular Synovitis Drug Sales Quantity by Type (2018-2034)
7.2.2 Europe Pigmented Villonodular Synovitis Drug Revenue by Type (2018-2034)
7.3 Europe Pigmented Villonodular Synovitis Drug Market Size by Application
7.3.1 Europe Pigmented Villonodular Synovitis Drug Sales Quantity by Application (2018-2034)
7.3.2 Europe Pigmented Villonodular Synovitis Drug Revenue by Application (2018-2034)
7.4 Europe Pigmented Villonodular Synovitis Drug Market Size by Country
7.4.1 Europe Pigmented Villonodular Synovitis Drug Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Pigmented Villonodular Synovitis Drug Revenue by Country (2018-2034)
7.4.3 Europe Pigmented Villonodular Synovitis Drug Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Pigmented Villonodular Synovitis Drug Sales by Company
8.1.1 China Pigmented Villonodular Synovitis Drug Sales Quantity by Company (2018-2023)
8.1.2 China Pigmented Villonodular Synovitis Drug Revenue by Company (2018-2023)
8.2 China Pigmented Villonodular Synovitis Drug Market Size by Type
8.2.1 China Pigmented Villonodular Synovitis Drug Sales Quantity by Type (2018-2034)
8.2.2 China Pigmented Villonodular Synovitis Drug Revenue by Type (2018-2034)
8.3 China Pigmented Villonodular Synovitis Drug Market Size by Application
8.3.1 China Pigmented Villonodular Synovitis Drug Sales Quantity by Application (2018-2034)
8.3.2 China Pigmented Villonodular Synovitis Drug Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Pigmented Villonodular Synovitis Drug Sales by Company
9.1.1 APAC Pigmented Villonodular Synovitis Drug Sales Quantity by Company (2018-2023)
9.1.2 APAC Pigmented Villonodular Synovitis Drug Revenue by Company (2018-2023)
9.2 APAC Pigmented Villonodular Synovitis Drug Market Size by Type
9.2.1 APAC Pigmented Villonodular Synovitis Drug Sales Quantity by Type (2018-2034)
9.2.2 APAC Pigmented Villonodular Synovitis Drug Revenue by Type (2018-2034)
9.3 APAC Pigmented Villonodular Synovitis Drug Market Size by Application
9.3.1 APAC Pigmented Villonodular Synovitis Drug Sales Quantity by Application (2018-2034)
9.3.2 APAC Pigmented Villonodular Synovitis Drug Revenue by Application (2018-2034)
9.4 APAC Pigmented Villonodular Synovitis Drug Market Size by Region
9.4.1 APAC Pigmented Villonodular Synovitis Drug Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Pigmented Villonodular Synovitis Drug Revenue by Region (2018-2034)
9.4.3 APAC Pigmented Villonodular Synovitis Drug Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Sales by Company
10.1.1 Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Market Size by Type
10.2.1 Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Market Size by Application
10.3.1 Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Market Size by Country
10.4.1 Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Bristol-Myers Squibb Co
11.1.1 Bristol-Myers Squibb Co Company Information
11.1.2 Bristol-Myers Squibb Co Overview
11.1.3 Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug Products and Services
11.1.5 Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug SWOT Analysis
11.1.6 Bristol-Myers Squibb Co Recent Developments
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Information
11.2.2 F. Hoffmann-La Roche Ltd Overview
11.2.3 F. Hoffmann-La Roche Ltd Pigmented Villonodular Synovitis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 F. Hoffmann-La Roche Ltd Pigmented Villonodular Synovitis Drug Products and Services
11.2.5 F. Hoffmann-La Roche Ltd Pigmented Villonodular Synovitis Drug SWOT Analysis
11.2.6 F. Hoffmann-La Roche Ltd Recent Developments
11.3 Novartis AG
11.3.1 Novartis AG Company Information
11.3.2 Novartis AG Overview
11.3.3 Novartis AG Pigmented Villonodular Synovitis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Novartis AG Pigmented Villonodular Synovitis Drug Products and Services
11.3.5 Novartis AG Pigmented Villonodular Synovitis Drug SWOT Analysis
11.3.6 Novartis AG Recent Developments
11.4 Plexxikon Inc
11.4.1 Plexxikon Inc Company Information
11.4.2 Plexxikon Inc Overview
11.4.3 Plexxikon Inc Pigmented Villonodular Synovitis Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Plexxikon Inc Pigmented Villonodular Synovitis Drug Products and Services
11.4.5 Plexxikon Inc Pigmented Villonodular Synovitis Drug SWOT Analysis
11.4.6 Plexxikon Inc Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Pigmented Villonodular Synovitis Drug Value Chain Analysis
12.2 Pigmented Villonodular Synovitis Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pigmented Villonodular Synovitis Drug Production Mode & Process
12.4 Pigmented Villonodular Synovitis Drug Sales and Marketing
12.4.1 Pigmented Villonodular Synovitis Drug Sales Channels
12.4.2 Pigmented Villonodular Synovitis Drug Distributors
12.5 Pigmented Villonodular Synovitis Drug Customers
13 Market Dynamics
13.1 Pigmented Villonodular Synovitis Drug Industry Trends
13.2 Pigmented Villonodular Synovitis Drug Market Drivers
13.3 Pigmented Villonodular Synovitis Drug Market Challenges
13.4 Pigmented Villonodular Synovitis Drug Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Pigmented Villonodular Synovitis Drug Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Cabiralizumab
Table 3. Major Manufacturers of Emactuzumab
Table 4. Major Manufacturers of Mcs-110
Table 5. Major Manufacturers of Nilotinib
Table 6. Major Manufacturers of Others
Table 7. Global Pigmented Villonodular Synovitis Drug Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Pigmented Villonodular Synovitis Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global Pigmented Villonodular Synovitis Drug Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Pigmented Villonodular Synovitis Drug Revenue Market Share by Region (2018-2023)
Table 11. Global Pigmented Villonodular Synovitis Drug Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Pigmented Villonodular Synovitis Drug Revenue Market Share by Region (2024-2034)
Table 13. Global Pigmented Villonodular Synovitis Drug Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 14. Global Pigmented Villonodular Synovitis Drug Sales by Region (2018-2023) & (K Pcs)
Table 15. Global Pigmented Villonodular Synovitis Drug Sales Market Share by Region (2018-2023)
Table 16. Global Pigmented Villonodular Synovitis Drug Sales by Region (2024-2034) & (K Pcs)
Table 17. Global Pigmented Villonodular Synovitis Drug Sales Market Share by Region (2024-2034)
Table 18. Global Pigmented Villonodular Synovitis Drug Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 19. Global Pigmented Villonodular Synovitis Drug Sales Quantity Share by Manufacturers (2018-2023)
Table 20. Global Pigmented Villonodular Synovitis Drug Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Pigmented Villonodular Synovitis Drug Revenue Share by Manufacturers (2018-2023)
Table 22. Global Pigmented Villonodular Synovitis Drug Price by Manufacturers 2018-2023 (USD/Pcs)
Table 23. Global Key Players of Pigmented Villonodular Synovitis Drug, Industry Ranking, 2021 VS 2024
Table 24. Global Pigmented Villonodular Synovitis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Pigmented Villonodular Synovitis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pigmented Villonodular Synovitis Drug as of 2024)
Table 26. Global Key Manufacturers of Pigmented Villonodular Synovitis Drug, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Pigmented Villonodular Synovitis Drug, Product Offered and Application
Table 28. Global Key Manufacturers of Pigmented Villonodular Synovitis Drug, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Pigmented Villonodular Synovitis Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 31. Global Pigmented Villonodular Synovitis Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 32. Global Pigmented Villonodular Synovitis Drug Sales Quantity Share by Type (2018-2023)
Table 33. Global Pigmented Villonodular Synovitis Drug Sales Quantity Share by Type (2024-2034)
Table 34. Global Pigmented Villonodular Synovitis Drug Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Pigmented Villonodular Synovitis Drug Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Pigmented Villonodular Synovitis Drug Revenue Share by Type (2018-2023)
Table 37. Global Pigmented Villonodular Synovitis Drug Revenue Share by Type (2024-2034)
Table 38. Pigmented Villonodular Synovitis Drug Price by Type (2018-2023) & (USD/Pcs)
Table 39. Global Pigmented Villonodular Synovitis Drug Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 40. Global Pigmented Villonodular Synovitis Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 41. Global Pigmented Villonodular Synovitis Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 42. Global Pigmented Villonodular Synovitis Drug Sales Quantity Share by Application (2018-2023)
Table 43. Global Pigmented Villonodular Synovitis Drug Sales Quantity Share by Application (2024-2034)
Table 44. Global Pigmented Villonodular Synovitis Drug Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Pigmented Villonodular Synovitis Drug Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Pigmented Villonodular Synovitis Drug Revenue Share by Application (2018-2023)
Table 47. Global Pigmented Villonodular Synovitis Drug Revenue Share by Application (2024-2034)
Table 48. Pigmented Villonodular Synovitis Drug Price by Application (2018-2023) & (USD/Pcs)
Table 49. Global Pigmented Villonodular Synovitis Drug Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 50. North America Pigmented Villonodular Synovitis Drug Revenue by Company (2018-2023) & (US$ Million)
Table 51. North America Pigmented Villonodular Synovitis Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 52. North America Pigmented Villonodular Synovitis Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 53. North America Pigmented Villonodular Synovitis Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 54. North America Pigmented Villonodular Synovitis Drug Revenue by Type (2018-2023) & (US$ Million)
Table 55. North America Pigmented Villonodular Synovitis Drug Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Pigmented Villonodular Synovitis Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 57. North America Pigmented Villonodular Synovitis Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 58. North America Pigmented Villonodular Synovitis Drug Revenue by Application (2018-2023) & (US$ Million)
Table 59. North America Pigmented Villonodular Synovitis Drug Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Pigmented Villonodular Synovitis Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 61. North America Pigmented Villonodular Synovitis Drug Revenue by Country (2018-2023) & (US$ Million)
Table 62. North America Pigmented Villonodular Synovitis Drug Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Pigmented Villonodular Synovitis Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 64. North America Pigmented Villonodular Synovitis Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 65. Europe Pigmented Villonodular Synovitis Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 66. Europe Pigmented Villonodular Synovitis Drug Revenue by Company (2018-2023) & (US$ Million)
Table 67. Europe Pigmented Villonodular Synovitis Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 68. Europe Pigmented Villonodular Synovitis Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 69. Europe Pigmented Villonodular Synovitis Drug Revenue by Type (2018-2023) & (US$ Million)
Table 70. Europe Pigmented Villonodular Synovitis Drug Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Pigmented Villonodular Synovitis Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 72. Europe Pigmented Villonodular Synovitis Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 73. Europe Pigmented Villonodular Synovitis Drug Revenue by Application (2018-2023) & (US$ Million)
Table 74. Europe Pigmented Villonodular Synovitis Drug Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Pigmented Villonodular Synovitis Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 76. Europe Pigmented Villonodular Synovitis Drug Revenue by Country (2018-2023) & (US$ Million)
Table 77. Europe Pigmented Villonodular Synovitis Drug Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Pigmented Villonodular Synovitis Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 79. Europe Pigmented Villonodular Synovitis Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 80. China Pigmented Villonodular Synovitis Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 81. China Pigmented Villonodular Synovitis Drug Revenue by Company (2018-2023) & (US$ Million)
Table 82. China Pigmented Villonodular Synovitis Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 83. China Pigmented Villonodular Synovitis Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 84. China Pigmented Villonodular Synovitis Drug Revenue by Type (2018-2023) & (US$ Million)
Table 85. China Pigmented Villonodular Synovitis Drug Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Pigmented Villonodular Synovitis Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 87. China Pigmented Villonodular Synovitis Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 88. China Pigmented Villonodular Synovitis Drug Revenue by Application (2018-2023) & (US$ Million)
Table 89. China Pigmented Villonodular Synovitis Drug Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Pigmented Villonodular Synovitis Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 91. APAC Pigmented Villonodular Synovitis Drug Revenue by Company (2018-2023) & (US$ Million)
Table 92. APAC Pigmented Villonodular Synovitis Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 93. APAC Pigmented Villonodular Synovitis Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 94. APAC Pigmented Villonodular Synovitis Drug Revenue by Type (2018-2023) & (US$ Million)
Table 95. APAC Pigmented Villonodular Synovitis Drug Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Pigmented Villonodular Synovitis Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 97. APAC Pigmented Villonodular Synovitis Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 98. APAC Pigmented Villonodular Synovitis Drug Revenue by Application (2018-2023) & (US$ Million)
Table 99. APAC Pigmented Villonodular Synovitis Drug Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Pigmented Villonodular Synovitis Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 101. APAC Pigmented Villonodular Synovitis Drug Revenue by Region (2018-2023) & (US$ Million)
Table 102. APAC Pigmented Villonodular Synovitis Drug Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Pigmented Villonodular Synovitis Drug Sales Quantity by Region (2018-2023) & (K Pcs)
Table 104. APAC Pigmented Villonodular Synovitis Drug Sales Quantity by Region (2024-2034) & (K Pcs)
Table 105. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Sales Quantity by Company (2018-2023) & (K Pcs)
Table 106. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Revenue by Company (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Sales Quantity by Type (2018-2023) & (K Pcs)
Table 108. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Sales Quantity by Type (2024-2034) & (K Pcs)
Table 109. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Revenue by Type (2018-2023) & (US$ Million)
Table 110. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Sales Quantity by Application (2018-2023) & (K Pcs)
Table 112. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Sales Quantity by Application (2024-2034) & (K Pcs)
Table 113. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Revenue by Application (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Revenue by Country (2018-2023) & (US$ Million)
Table 117. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Sales Quantity by Country (2018-2023) & (K Pcs)
Table 119. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Sales Quantity by Country (2024-2034) & (K Pcs)
Table 120. Bristol-Myers Squibb Co Company Information
Table 121. Bristol-Myers Squibb Co Description and Overview
Table 122. Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 123. Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug Product and Services
Table 124. Bristol-Myers Squibb Co Pigmented Villonodular Synovitis Drug SWOT Analysis
Table 125. Bristol-Myers Squibb Co Recent Developments
Table 126. F. Hoffmann-La Roche Ltd Company Information
Table 127. F. Hoffmann-La Roche Ltd Description and Overview
Table 128. F. Hoffmann-La Roche Ltd Pigmented Villonodular Synovitis Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 129. F. Hoffmann-La Roche Ltd Pigmented Villonodular Synovitis Drug Product and Services
Table 130. F. Hoffmann-La Roche Ltd Pigmented Villonodular Synovitis Drug SWOT Analysis
Table 131. F. Hoffmann-La Roche Ltd Recent Developments
Table 132. Novartis AG Company Information
Table 133. Novartis AG Description and Overview
Table 134. Novartis AG Pigmented Villonodular Synovitis Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 135. Novartis AG Pigmented Villonodular Synovitis Drug Product and Services
Table 136. Novartis AG Pigmented Villonodular Synovitis Drug SWOT Analysis
Table 137. Novartis AG Recent Developments
Table 138. Plexxikon Inc Company Information
Table 139. Plexxikon Inc Description and Overview
Table 140. Plexxikon Inc Pigmented Villonodular Synovitis Drug Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 141. Plexxikon Inc Pigmented Villonodular Synovitis Drug Product and Services
Table 142. Plexxikon Inc Pigmented Villonodular Synovitis Drug SWOT Analysis
Table 143. Plexxikon Inc Recent Developments
Table 144. Key Raw Materials Lists
Table 145. Raw Materials Key Suppliers Lists
Table 146. Pigmented Villonodular Synovitis Drug Distributors List
Table 147. Pigmented Villonodular Synovitis Drug Customers List
Table 148. Pigmented Villonodular Synovitis Drug Market Trends
Table 149. Pigmented Villonodular Synovitis Drug Market Drivers
Table 150. Pigmented Villonodular Synovitis Drug Market Challenges
Table 151. Pigmented Villonodular Synovitis Drug Market Restraints
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Pigmented Villonodular Synovitis Drug Product Picture
Figure 2. Global Pigmented Villonodular Synovitis Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Pigmented Villonodular Synovitis Drug Market Share by Type in 2024 & 2034
Figure 4. Cabiralizumab Product Picture
Figure 5. Emactuzumab Product Picture
Figure 6. Mcs-110 Product Picture
Figure 7. Nilotinib Product Picture
Figure 8. Others Product Picture
Figure 9. Global Pigmented Villonodular Synovitis Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 10. Global Pigmented Villonodular Synovitis Drug Market Share by Application in 2024 & 2034
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Others
Figure 14. Pigmented Villonodular Synovitis Drug Report Years Considered
Figure 15. Global Pigmented Villonodular Synovitis Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global Pigmented Villonodular Synovitis Drug Revenue 2018-2034 (US$ Million)
Figure 17. Global Pigmented Villonodular Synovitis Drug Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 18. Global Pigmented Villonodular Synovitis Drug Sales Quantity 2018-2034 (K Pcs)
Figure 19. Global Pigmented Villonodular Synovitis Drug Sales Quantity Market Share by Region (2018-2023)
Figure 20. Global Pigmented Villonodular Synovitis Drug Sales Quantity Market Share by Region (2024-2034)
Figure 21. North America Pigmented Villonodular Synovitis Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 22. North America Pigmented Villonodular Synovitis Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 23. Europe Pigmented Villonodular Synovitis Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 24. Europe Pigmented Villonodular Synovitis Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 25. China Pigmented Villonodular Synovitis Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 26. China Pigmented Villonodular Synovitis Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 27. APAC Pigmented Villonodular Synovitis Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 28. APAC Pigmented Villonodular Synovitis Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 30. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Pigmented Villonodular Synovitis Drug Sales Quantity in 2024
Figure 32. The Top 10 and Top 5 Players Market Share by Pigmented Villonodular Synovitis Drug Revenue in 2024
Figure 33. Pigmented Villonodular Synovitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 34. Global Pigmented Villonodular Synovitis Drug Sales Quantity Market Share by Type (2018-2034)
Figure 35. Global Pigmented Villonodular Synovitis Drug Revenue Market Share by Type (2018-2034)
Figure 36. Global Pigmented Villonodular Synovitis Drug Sales Quantity Market Share by Application (2018-2034)
Figure 37. Global Pigmented Villonodular Synovitis Drug Revenue Market Share by Application (2018-2034)
Figure 38. North America Pigmented Villonodular Synovitis Drug Revenue Market Share by Company in 2024
Figure 39. North America Pigmented Villonodular Synovitis Drug Sales Quantity Market Share by Company in 2024
Figure 40. North America Pigmented Villonodular Synovitis Drug Sales Quantity Market Share by Type (2018-2034)
Figure 41. North America Pigmented Villonodular Synovitis Drug Revenue Market Share by Type (2018-2034)
Figure 42. North America Pigmented Villonodular Synovitis Drug Sales Quantity Market Share by Application (2018-2034)
Figure 43. North America Pigmented Villonodular Synovitis Drug Revenue Market Share by Application (2018-2034)
Figure 44. North America Pigmented Villonodular Synovitis Drug Revenue Share by Country (2018-2034)
Figure 45. North America Pigmented Villonodular Synovitis Drug Sales Quantity Share by Country (2018-2034)
Figure 46. U.S. Pigmented Villonodular Synovitis Drug Revenue (2018-2034) & (US$ Million)
Figure 47. Canada Pigmented Villonodular Synovitis Drug Revenue (2018-2034) & (US$ Million)
Figure 48. Europe Pigmented Villonodular Synovitis Drug Sales Quantity Market Share by Company in 2024
Figure 49. Europe Pigmented Villonodular Synovitis Drug Revenue Market Share by Company in 2024
Figure 50. Europe Pigmented Villonodular Synovitis Drug Sales Quantity Market Share by Type (2018-2034)
Figure 51. Europe Pigmented Villonodular Synovitis Drug Revenue Market Share by Type (2018-2034)
Figure 52. Europe Pigmented Villonodular Synovitis Drug Sales Quantity Market Share by Application (2018-2034)
Figure 53. Europe Pigmented Villonodular Synovitis Drug Revenue Market Share by Application (2018-2034)
Figure 54. Europe Pigmented Villonodular Synovitis Drug Revenue Share by Country (2018-2034)
Figure 55. Europe Pigmented Villonodular Synovitis Drug Sales Quantity Share by Country (2018-2034)
Figure 56. Germany Pigmented Villonodular Synovitis Drug Revenue (2018-2034) & (US$ Million)
Figure 57. France Pigmented Villonodular Synovitis Drug Revenue (2018-2034) & (US$ Million)
Figure 58. U.K. Pigmented Villonodular Synovitis Drug Revenue (2018-2034) & (US$ Million)
Figure 59. Italy Pigmented Villonodular Synovitis Drug Revenue (2018-2034) & (US$ Million)
Figure 60. Russia Pigmented Villonodular Synovitis Drug Revenue (2018-2034) & (US$ Million)
Figure 61. China Pigmented Villonodular Synovitis Drug Sales Quantity Market Share by Company in 2024
Figure 62. China Pigmented Villonodular Synovitis Drug Revenue Market Share by Company in 2024
Figure 63. China Pigmented Villonodular Synovitis Drug Sales Quantity Market Share by Type (2018-2034)
Figure 64. China Pigmented Villonodular Synovitis Drug Revenue Market Share by Type (2018-2034)
Figure 65. China Pigmented Villonodular Synovitis Drug Sales Quantity Market Share by Application (2018-2034)
Figure 66. China Pigmented Villonodular Synovitis Drug Revenue Market Share by Application (2018-2034)
Figure 67. APAC Pigmented Villonodular Synovitis Drug Sales Quantity Market Share by Company in 2024
Figure 68. APAC Pigmented Villonodular Synovitis Drug Revenue Market Share by Company in 2024
Figure 69. APAC Pigmented Villonodular Synovitis Drug Sales Quantity Market Share by Type (2018-2034)
Figure 70. APAC Pigmented Villonodular Synovitis Drug Revenue Market Share by Type (2018-2034)
Figure 71. APAC Pigmented Villonodular Synovitis Drug Sales Quantity Market Share by Application (2018-2034)
Figure 72. APAC Pigmented Villonodular Synovitis Drug Revenue Market Share by Application (2018-2034)
Figure 73. APAC Pigmented Villonodular Synovitis Drug Revenue Share by Region (2018-2034)
Figure 74. APAC Pigmented Villonodular Synovitis Drug Sales Quantity Share by Region (2018-2034)
Figure 75. Japan Pigmented Villonodular Synovitis Drug Revenue (2018-2034) & (US$ Million)
Figure 76. South Korea Pigmented Villonodular Synovitis Drug Revenue (2018-2034) & (US$ Million)
Figure 77. China Taiwan Pigmented Villonodular Synovitis Drug Revenue (2018-2034) & (US$ Million)
Figure 78. Southeast Asia Pigmented Villonodular Synovitis Drug Revenue (2018-2034) & (US$ Million)
Figure 79. India Pigmented Villonodular Synovitis Drug Revenue (2018-2034) & (US$ Million)
Figure 80. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Sales Quantity Market Share by Company in 2024
Figure 81. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Revenue Market Share by Company in 2024
Figure 82. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Sales Quantity Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Revenue Market Share by Type (2018-2034)
Figure 84. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Sales Quantity Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Revenue Market Share by Application (2018-2034)
Figure 86. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Sales Quantity Share by Country (2018-2034)
Figure 87. Middle East, Africa and Latin America Pigmented Villonodular Synovitis Drug Revenue Share by Country (2018-2034)
Figure 88. Brazil Pigmented Villonodular Synovitis Drug Revenue (2018-2034) & (US$ Million)
Figure 89. Mexico Pigmented Villonodular Synovitis Drug Revenue (2018-2034) & (US$ Million)
Figure 90. Turkey Pigmented Villonodular Synovitis Drug Revenue (2018-2034) & (US$ Million)
Figure 91. Israel Pigmented Villonodular Synovitis Drug Revenue (2018-2034) & (US$ Million)
Figure 92. GCC Countries Pigmented Villonodular Synovitis Drug Revenue (2018-2034) & (US$ Million)
Figure 93. Pigmented Villonodular Synovitis Drug Value Chain
Figure 94. Pigmented Villonodular Synovitis Drug Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed